Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The HIV-1 regulatory proteins Rev and Tat are expressed early in the virus life cycle and thus may be important targets for the immune control of HIV-1-infection and for effective vaccines. However, the extent to which these proteins are targeted in natural HIV-1 infection as well as precise epitopes targeted by human cytotoxic T lymphocytes (CTL) remain to be defined. In the present study, 57 HIV-1-infected individuals were screened for responses against Tat and Rev by using overlapping peptides spanning the entire Tat and Rev proteins. CD8+ T cell responses against Tat and Rev were found in up to 19 and 37% of HIV-1-infected individuals, respectively, indicating that these regulatory proteins are important targets for HIV-1-specific CTL. Despite the small size of these proteins, multiple CTL epitopes were identified in each. These data indicate that Tat and Rev are frequently targeted by CTL in natural HIV-1 infection and may be important targets for HIV vaccines.

Original publication

DOI

10.1073/pnas.98.4.1781

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

13/02/2001

Volume

98

Pages

1781 - 1786

Keywords

CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Gene Products, rev, Gene Products, tat, HIV Infections, HIV-1, Humans, Longitudinal Studies, Peptides, T-Lymphocytes, Cytotoxic, rev Gene Products, Human Immunodeficiency Virus, tat Gene Products, Human Immunodeficiency Virus